Contrast enhanced magnetic resonance imaging for uterine artery embolization efficiency assessment in women with leiomyoma uteri

In: Опухоли женской репродуктивной системы, Vol 0, Iss 3, Pp 64-69 (2014) · 2014 · doi:10.17650/1994-4098-2014-0-3-64-69 · W2598059932
article OA: green CC0
AI-generated summary by gemini-2.5-flash-lite, 2026-07-17

Contrast-enhanced MRI effectively assesses uterine artery embolization efficiency by visualizing leiomyoma shrinkage and lack of enhancement post-procedure, and can predict treatment response and complications.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Uterine artery embolization (UAE) is minimally invasive, less complicated and uterine-preserve procedure when compared to traditional surgical options. Magnetic resonance imaging (MRI) is the preferred modality in gynecologic pathology visualization. MRI is more accurate than transvaginal ultrasound in evaluating number, size and structure of the fibroids as well as their vascularization (by means of contrast enhancement) on pre-UAE uterus. On post-UAE contrast enhanced MRI, performed in 1, 6 and 12 month after the procedure, shrinkage of fibroids as well as the absence of their enhancement can be registered, showing the success or the manipulation. In case when leiomyoma is accompanied with adenomyosis, poor response of UAE can be noted by means of enhanced MRI revealing revascularization of fibroids. Thus, enhanced MRI is essential in UAE efficiency assessment, predicting treatment response and it’s complications.

My notes (saved in your browser only)

Condition tags

adenomyosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK